Louisiana's share of EpiPen overbilling settlement is $6.9M
BATON ROUGE - Louisiana is getting $6.9 million from EpiPen maker Mylan as part of a national settlement.
Attorney General Jeff Landry announced the state's share of the $465 million federal agreement completed in August that settled allegations it overbilled Medicaid programs for its emergency allergy injectors for nearly a decade.
Landry called it Medicaid fraud. In a statement, he said people and companies that "deceive the hard-working taxpayers of Louisiana should be held accountable for their actions."
It's the second settlement with the U.S. Department of Justice that Mylan has made since 2009 for allegedly overcharging the government. The latest case involves Mylan paying Medicaid too-low rebates for the devices by classifying its brand-name product as a generic, which requires lower rebates.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Police investigating string of similar robberies in Garden District area
Department of Wildlife and Fisheries urging boaters to stay safe ahead of...
Woman still searching for answers in mother's mysterious 2008 death
Storage facility's mistake caused disabled man's belongings to be thrown in the...
House struck by stray bullet after gunfire erupted on I-10
Southern baseball wins game one 21-2 over Alcorn
VIDEO: Former Saints and Tiger Devery Henderson talks about the difference between...
New NCAA rules tweak opens door for more SEC dominance
VIDEO: Devery Henderson Talk about Bluegrass Miracle and the Saints "Rebirth game"
VIDEO: Former Tigers and Saints receiver Devery Henderson talks with Corey Rholdon...